www.seeingmachines.com
Seeing Machines is an award winning technology company with a focus on vision based human machine interfaces. Seeing Machines technology platform is based on world-leading computer vision processing technologies that allow machines to see and track human faces and certain facial features. These technologies enable the development of new cutting edge products and applications, ranging from devices that improve road safety & save lives, to those that help manage eye disease and prevent loss of eyesight.
The company’s focus is on deploying its computer vision technologies, worldwide, in:
- Driver/operator safety products for transport markets through the DSS product range;
- The TrueField Analyzer® (TFA) product for vision testing devices for healthcare markets;
- New products in a range of markets including sports, entertainment, robotics and security through our faceAPI product; and
- Human performance measurement through our faceLAB® product.
Seeing Machines Making Transition into a More Commercially Focused Company
At its AGM, Seeing Machines (AIM: SEE) highlighted its previously reported 19% increase in full-year revenues and said it is progressing in its transition to a much more commercially focused company. The computer vision systems developer held AGM earlier today in Canberra, Australia.
Aside from the company’s revenue growth, Seeing Machines CEO Nick Cerneaz acknowledged that 2009 has been a difficult year, but emphasised the technology company’s good pipeline of opportunities. Specifically Seeing Machines took the opportunity to update investors on three key commercial developments among the group’s product applications.
Firstly the company said its DSS (Driver State Sensor) technology has made progress in strategic mining and commercial transport sectors, with significant opportunities in the sales pipeline. Seeing Machines has focused on extensive marketing and business development efforts in these sectors through the financial year and generated sales through large scale pilot deployments within resource and industrial operations.
A second major development was the launch of the TrueField Analyzer (TFA), a device for ophthalmic vision testing initially focused on the glaucoma market. The TFA is available initially on limited release in the US.
The new faceAPI product represents the third area of development. Due to the extensive range of applications for the company’s head and eye tracking technology, Seeing Machines has developed a software development platform to enable third party developers to embed it’s technology in third party applications.
Seeing Machines said the software licensing and royalty based business model has exceeded its budgeted revenue expectations in its first full financial year since its release. The company is hopeful that it will convert a number of opportunities into new production licenses for the faceAPI and will announce further progress to the market in due course.
